Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection

Candidate human immunodeficiency virus type 1 (HIV-1) vaccines designed to elicit T-cell immunity in HIV-1-uninfected persons are under investigation in phase I to III clinical trials. Little is known about how these vaccines impact the immunologic response postinfection in persons who break through...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Horton, Helen, Havenar-Daughton, Colin, Lee, Deborah, Moore, Erin, Cao, Jianhong, McNevin, John, Andrus, Thomas, Zhu, Haiying, Rubin, Abbe, Zhu, Tuofu, Celum, Connie, McElrath, M. Juliana
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2006
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1617262/
https://ncbi.nlm.nih.gov/pubmed/16973582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00794-06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires